Cooper Companies Inc represents a strong set of values and a corporate philosophy that guides its operations. With a focus on innovation, Cooper Companies Inc strives to deliver cutting-edge products and services to its customers. The company emphasizes ethical business practices, integrity, and a commitment to improving global healthcare. Cooper Companies Inc understands the importance of sustainability and actively seeks ways to minimize its environmental impact. By consistently prioritizing customer needs, investing in research and development, and fostering a diverse and inclusive workplace, Cooper Companies Inc demonstrates its dedication to growth, excellence, and making a positive difference in the world.

Cooper Companies Inc is primarily present in multiple countries and regions around the world. With its global presence, the company has established a strong foothold in various markets. These include the United States, where it is headquartered, as well as other significant regions such as Europe, Asia, and Latin America. Cooper Companies Inc has successfully expanded its reach and market penetration across these regions, showcasing its commitment to serving a diverse and international customer base.

Cooper Companies Inc has achieved significant milestones throughout its history. One of its major achievements was the acquisition of Ocular Sciences Inc in 2005, which allowed the company to expand its footprint in the contact lens industry. Another milestone was the development and launch of innovative products such as Biofinity Energys, a contact lens designed for digital device users. Additionally, the company received FDA approval for its MyDay daily disposable contact lenses, further strengthening its product portfolio. Cooper Companies Inc has also been recognized for its commitment to corporate social responsibility, receiving multiple awards for its sustainability efforts.

Cooper Companies Inc, founded in 1958, is a global medical device company with a rich history and commendable background. It specializes in the development, manufacture, and distribution of contact lenses, surgical tools, and accessories for healthcare professionals and individuals worldwide. Over time, Cooper Companies Inc has become a leading player in the vision care industry, epitomized by its reputable brands, including CooperVision and CooperSurgical. With a commitment to innovation, quality, and precision, the company has continuously evolved and expanded its product portfolio to cater to the ever-changing needs of its customers. Today, Cooper Companies Inc stands as a trusted name, backed by its remarkable track record and dedication to enhancing vision and healthcare outcomes for countless individuals.

The main competitors of Cooper Companies Inc in the market include Johnson & Johnson, Alcon Inc., Bausch Health Companies Inc., and Carl Zeiss Meditec AG.

Cooper Companies Inc is primarily active in the healthcare industry, specifically focusing on two segments. The company operates in the medical devices industry through its subsidiary CooperSurgical, which specializes in women's healthcare products and services. Cooper Companies Inc also has a presence in the global vision care industry through its subsidiary CooperVision, which provides a wide range of contact lenses and related products. With its focus on healthcare, Cooper Companies Inc plays a crucial role in improving and maintaining the well-being of individuals in these industries.

Cooper Companies Inc's business model revolves around providing medical devices and contact lenses. As a leading global provider in these markets, the company focuses on developing, manufacturing, and selling a wide range of innovative products. Cooper Companies Inc aims to enhance the quality of vision and improve the overall healthcare experience for its customers worldwide. By leveraging its expertise and technology, the company strives to deliver exceptional results while meeting the diverse needs of individuals and eye care professionals. Through a combination of research, development, and strategic partnerships, Cooper Companies Inc aims to drive growth and maintain its position as a trusted leader in the industry.

Cooper Companies의 P/E 비율은 23.97입니다.

Cooper Companies의 P/S 비율은 4.39입니다.

Cooper Companies에 대한 AlleAktien 품질 점수는 7/10입니다.

예상되는 Cooper Companies 매출은 3.93 조. USD입니다.

예상되는 Cooper Companies 이익은 718.81 백만 USD입니다.

Cooper Companies is an international corporation based in Pleasanton, California. The company specializes in the development, manufacturing, and distribution of medical products. It focuses on two divisions: CooperVision and CooperSurgical. CooperVision is the world's leading manufacturer of contact lenses. The company offers a wide range of lenses for different needs, such as daily, monthly, and yearly lenses. It also offers special types of lenses, such as multifocal lenses or toric lenses, which can correct specific vision problems. Additionally, CooperVision provides lens care products and accessories. CooperSurgical is a leading provider of medical instruments and devices in the field of gynecology and obstetrics. The company offers a wide range of products, including diagnostic and therapeutic instruments, as well as surgical instruments and devices. It also offers products for women's reproductive health, such as fertility tests, pregnancy tests, or in-vitro fertilization (IVF) products. In addition to these two divisions, Cooper Companies also has a smaller business unit called CooperVision Specialty EyeCare. This innovative department offers special contact lenses for correcting vision problems that cannot be corrected with conventional contact lenses. Another business segment of Cooper Companies is the development and manufacturing of medical devices for the treatment of retinal diseases. These devices contribute to the treatment of conditions such as age-related macular degeneration, diabetic retinopathy, and macular edema. Cooper Companies distributes its products worldwide. The company's main markets are North America and Europe, but it is also expanding into emerging markets such as Asia and Latin America. Cooper Companies operates distribution subsidiaries in over 100 countries and employs more than 12,000 people worldwide. Cooper Companies' business model is focused on sustainable expansion through organic growth and strategic acquisitions. The company has made a number of acquisitions in the past to expand its product range and strengthen its market position. Overall, Cooper Companies' business model is heavily focused on meeting the needs of its customers. The company strives to provide innovative products and solutions that contribute to improving the health and well-being of people worldwide.

Cooper Companies은(는) 연간 2번의 배당을 통해 0.06 USD의 배당금을 지급합니다.

Cooper Companies는 연간 2번의 배당금을 지급합니다.

Cooper Companies의 ISIN은 US2166484020입니다.

Cooper Companies의 WKN은 867409입니다.

Cooper Companies의 티커는 COO입니다.

지난 12개월 동안 Cooper Companies은(는) 0.06 USD 의 배당금을 지급했습니다. 이는 약 0.07 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Cooper Companies은(는) 0.06 USD의 배당금을 지급할 것으로 예상됩니다.

Cooper Companies의 현재 배당 수익률은 0.07 %입니다.

Cooper Companies은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Cooper Companies은(는) 지난 26년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0.06 USD의 배당금이 예상됩니다. 이는 배당수익률 0.07 %에 해당합니다.

Cooper Companies은 '건강' 섹터에 속합니다.

Cooper Companies의 마지막 배당금을 0.03 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Cooper Companies는 0.06 USD를 배당금으로 지급했습니다.

Cooper Companies의 배당금은 USD에 지급됩니다.